EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
about
The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.Effects of lapatinib on cell proliferation and apoptosis in NB4 cells.Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.
P2860
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
@en
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
@nl
type
label
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
@en
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
@nl
prefLabel
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
@en
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
@nl
P2093
P2860
P1476
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
@en
P2093
Barbara A Burtness
Cara Dubyk
David Sarcu
Elena I Shagisultanova
Elizabeth A Handorf
Erica A Golemis
Igor Astsaturov
Ilya G Serebriiskii
John A Ridge
Miriam N Lango
P2860
P304
P356
10.1158/1535-7163.MCT-16-0243
P577
2016-08-09T00:00:00Z